Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

METFORMIN IMPURITY F CRS (2 ML)

METFORMIN IMPURITY F CRS (2 ML)

NA

DISCOVER
Alfacalcidol for system suitability

Alfacalcidol for system suitability

41294-56-8

DISCOVER
DUTASTERIDE FOR SYSTEM SUITABILITY CRS (15 MG)

DUTASTERIDE FOR SYSTEM SUITABILITY CRS (15 MG)

164656-23-9

DISCOVER
FINASTERIDE FOR PEAK IDENTIFICATION CRS (15 MG)

FINASTERIDE FOR PEAK IDENTIFICATION CRS (15 MG)

NA

DISCOVER
EUCOMMIA BARK HRS (2100 MG)

EUCOMMIA BARK HRS (2100 MG)

NA

DISCOVER
FLEECEFLOWER ROOT HRS (300 MG)

FLEECEFLOWER ROOT HRS (300 MG)

NA

DISCOVER
BELAMCANDA CHINENSIS RHIZOME HRS (110 MG)

BELAMCANDA CHINENSIS RHIZOME HRS (110 MG)

NA

DISCOVER
NORFLURANE - REFERENCE SPECTRUM (N/A)

NORFLURANE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
TACALCITOL FOR SYSTEM SUITABILITY CRS (0.025 MG)

TACALCITOL FOR SYSTEM SUITABILITY CRS (0.025 MG)

93129-94-3

DISCOVER
ESCULETIN CRS (25 MG)

ESCULETIN CRS (25 MG)

305-01-1

DISCOVER
ESCULIN CRS (25 MG)

ESCULIN CRS (25 MG)

531-75-9

DISCOVER
CLEMASTINE FOR SYSTEM SUITABILITY CRS (0.165 MG)

CLEMASTINE FOR SYSTEM SUITABILITY CRS (0.165 MG)

14976-57-9

DISCOVER